Clinical trial
Role of Insulin Action in Psoriasis Pathogenesis
NCT06242847
Study timeline
Study start (actual)2024-02-02Date precision: day
Registry last updated2026-02-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Psoriasisunresolved
Plaque Psoriasisunresolved
Insulin Resistanceunresolved
PreDiabetesunresolved
Overweight and Obesityunresolved
Interventions
Oral glucose tolerance test (OGTT)DIAGNOSTIC_TEST
Skin punch biopsyPROCEDURE
Sponsors & collaborators
Columbia Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06242847 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.